Understanding the prognosis of diabetic foot ulcers
Official title: Prognostic Determinants in Patients With Diabetic Foot Ulcer (PDF Cohort) - A French Prospective Multicentre Cohort.
Run by University Hospital, Bordeaux · NCT04533152 · Data updated 2026-11-12
This study looks at how long people with diabetic foot ulcers live and what affects their health over five years, while also checking how these ulcers impact their quality of life and healthcare costs in France.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 26 sites (Caen and 25 other locations) |
| Status | Recruiting |
| Started | November 24, 2021 |
| Main results expected | November 2029 |
| Study ends | November 2029 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT04533152 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults with diabetes who have a diabetic foot ulcer measuring at least 5 mm in diameter.
✕Probably not a fit
Patients with acute or chronic lower-limb ischemia without an open skin wound or those with foot infections without open skin wounds may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the 5-year mortality rate and its causes in patients with diabetic foot ulcers (DFU) across multiple centers in France. It seeks to identify relevant prognostic determinants beyond cardiovascular risks, including inflammatory, infectious, and malignant conditions. The study will also assess changes in health-related quality of life and the economic impact of DFU on the French healthcare system using claims databases. Participants will be followed for five years or until death, providing valuable insights into the long-term outcomes of DFU.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of diabetic foot ulcers, potentially reducing mortality and enhancing quality of life for patients.
How similar studies have gone: While there have been studies on diabetic foot ulcers, this specific approach focusing on a multi-center cohort and comprehensive prognostic determinants is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Adults with diabetes and DFU, defined as a foot skin ulceration or open LLA wound, measuring at least 5 mm of diameter, located below the malleolus, and induced by diabetic complications. In the case of an amputation before inclusion, the amputation stump will be considered as the main wound and not the wound that led to the amputation. Exclusion Criteria: * Acute or chronic lower-limb ischemia without open skin wound, * Foot infection without open skin wound, * Intercurrent disease prohibiting participation in an observational study, * Pregnancy or breastfeeding * Curatorship or guardianship * Prisoners -- Patient currently participating to more than one other clinical study (interventional or observational, 2 study maximum including PDF) or currently participating to another study interfering with standard care of diabetic foot
Where it's running
-
CHU Côte de Nacre
Caen, France Recruiting -
CH Sud Francilien
Corbeil-Essonnes, France Recruiting -
CHU de Bocage Sud
Dijon, France Recruiting -
CHU de La Réunion - Site Sud
La Réunion, France Recruiting -
Groupe Hospitalier de La Rochelle Ré Aunis
La Rochelle, France Recruiting -
CHRU de Lille - Hôpital Claude Huriez
Lille, France Recruiting
Show 20 more locations
-
AP - HM - Hôpital de la Conception
Marseille, France Recruiting -
CHU de Montpellier - Hôpital Lapeyronie
Montpellier, France Recruiting -
CHU de Nantes Hôpital Nord Laennec
Nantes, France Recruiting -
CH Pierre Bérégovoy
Nevers, France Recruiting -
CHU de Nice - Hôpital l'Archet 2
Nice, France Recruiting -
AP-HP - Hôpital Bichat
Paris, France Recruiting -
AP-HP - Hôpital Lariboisière
Paris, France Recruiting -
AP-HP - Hôpital Pitié-Salpétrière
Paris, France Recruiting -
Hôpital Paris Saint Joseph
Paris, France Recruiting -
Hopital Haut-Leveque
Pessac, France Recruiting -
HCL - Hôpital Lyon sud
Pierre-Bénite, France Recruiting -
CHU de la Milétrie
Poitiers, France Recruiting -
CHU de Rouen
Rouen, France Recruiting -
Centre Hospitalier Saint Benoit
Saint-Benoît, France Recruiting -
Hôpital d'Instruction des Armées Bégin
Saint-Mandé, France Recruiting -
Maison de Santé Protestante Bagatelle - Hôpital Bagatelle
Talence, France Recruiting -
CHU de Toulouse - Hôpital Rangueil
Toulouse, France Recruiting -
Hôtel Dieu
Le Creusot, France Not yet recruiting -
CHU Nîmes - Hôpital universitaire Carémeau
Nîmes, France Not yet recruiting -
CHU de la Martinique
Fort-de-France, Martinique Withdrawn
Study contacts
- Study coordinator: Kamel MOHAMMEDI, Pr
- Email: kamel.mohammedi@chu-bordeaux.fr
- Phone: 5 57 65 60 78
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
BIOxHEAL plus standard care for nonhealing diabetic foot ulcers
A multicenter study tests whether applying BIOxHEAL, a placental-derived biologic, to stubborn diabetic foot ulcers helps more people heal when added to standard wound care.
-
Calcaneal Bone Marrow Cells in Foot/Ankle Surgery Patients
This observational study tests whether routine preoperative blood tests relate to the quality and behavior of mesenchymal stem cells from calcaneal bone marrow in adults undergoing foot or ankle surgery.
-
L-Carnitine as an add-on for healing diabetic foot ulcers
This study tests whether taking L-Carnitine helps wound healing in adults with diabetic foot ulcers, alongside standard diabetes and wound care.
-
THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers
This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.
-
Pulsating electromagnetic field therapy for diabetic foot ulcers
This trial tests whether a PEMF device called CRAD ULCER X-01 helps heal chronic diabetic foot ulcers when added to standard wound care.
-
Transverse tibial bone transport to help heal chronic diabetic foot ulcers
This study tests a surgical approach called transverse tibial bone transport to see if it can help heal long‑lasting diabetic foot ulcers and prevent limb loss in adults with limited treatment options.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.